Filtered By:
Specialty: Cardiology
Procedure: Heart Valve Surgery

This page shows you your search results in order of relevance. This is page number 18.

Order by Relevance | Date

Total 1031 results found since Jan 2013.

Transcatheter Aortic Valve Implantation for Pure Severe Native Aortic Valve Regurgitation
Conclusions: This registry analysis demonstrates the feasibility and potential procedure difficulties when using TAVI for severe NAVR. Acceptable results may be achieved in carefully selected patients who are deemed too high risk for conventional surgery, but the possibility of requiring 2 valves and leaving residual aortic regurgitation remain important considerations.
Source: Journal of the American College of Cardiology - February 25, 2013 Category: Cardiology Authors: David A. Roy, Ulrich Schaefer, Victor Guetta, David Hildick-Smith, Helge Möllmann, Nicholas Dumonteil, Thomas Modine, Johan Bosmans, Anna Sonia Petronio, Neil Moat, Axel Linke, Cesar Moris, Didier Champagnac, Radoslaw Parma, Andrzej Ochala, Diego Medvedo Tags: Interventional Cardiology Source Type: research

5-Year Experience With Transcatheter Transapical Mitral Valve-in-Valve Implantation for Bioprosthetic Valve Dysfunction
ObjectivesThe study sought to describe the authors' experience with mitral transapical transcatheter valve-in-valve implantation (TVIV).BackgroundIncreasing numbers of mitral biological prostheses are being implanted in clinical practice. Transcatheter valve-in-valve implantation may be a lower risk alternative treatment for high-risk patients with mitral valve degeneration.MethodsTwenty-three consecutive patients with severe mitral bioprosthetic valve dysfunction underwent transapical mitral TVIV between July 2007 and September 2012. Bioprosthetic failure was secondary to stenosis in 6 (26.1%), regurgitation in 9 (39.1%),...
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - April 22, 2013 Category: Cardiology Source Type: research

Two-Year Outcomes for Patients With Severe Symptomatic Aortic Stenosis Treated With Transcatheter Aortic Valve Implantation
In conclusion, the clinical outcome of TAVI is favorable. The use of both procedural devices and multiple techniques in the same institution is feasible and potentially desirable.
Source: The American Journal of Cardiology - February 18, 2013 Category: Cardiology Authors: Pablo Codner, Abid Assali, Danny Dvir, Hana Vaknin-Assa, Eyal Porat, Yaron Shapira, Marina Kupershmidt, Tamir Bental, Alexander Battler, Alexander Sagie, Ran Kornowski Tags: Valvular Heart Disease Source Type: research

Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: Results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial
Conclusions: Overall, PTMA had mild impact on MR reduction, left ventricular remodeling, QOL, and exercise capacity. During follow-up, the risk/benefit ratio remained suboptimal.
Source: American Heart Journal - February 18, 2013 Category: Cardiology Authors: Jimmy MacHaalany, Luc Bilodeau, Rainer Hoffmann, Stefan Sack, Horst Sievert, Josef Kautzner, Christoph Hehrlein, Patrick Serruys, Mario Sénéchal, Pamela Douglas, Olivier F. Bertrand Tags: Valvular and Congenital Heart Disease Source Type: research

Effect of Transcatheter (via Femoral Artery) Aortic Valve Implantation on the Platelet Count and Its Consequences
In conclusion, a decrease in platelet count is a common phenomenon after TAVI, and its severity is associated with poor outcomes.
Source: The American Journal of Cardiology - March 25, 2013 Category: Cardiology Authors: Romain Gallet, Aurelien Seemann, Masanori Yamamoto, Delphine Hayat, Gauthier Mouillet, Jean-Luc Monin, Pascal Gueret, Jean-Paul Couetil, Jean-Luc Dubois-Randé, Emmanuel Teiger, Pascal Lim Tags: Valvular Heart Disease Source Type: research

Percutaneous Endocardial Occlusion of Incompletely Surgically‐Ligated Left Atrial Appendage
ConclusionPercutaneous endocardial occlusion of ISLL is feasible using an Amplatzer Septal Occluder device. Additional studies are required to evaluate the long term safety and efficacy of this therapeutic treatment strategy in patients with ISLL.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - May 1, 2013 Category: Cardiology Authors: ARASH ARYANA, DIOGO CAVACO, ARVIN ARTHUR, PADRAIG GEAROID O'NEILL, PEDRO ADRAGÃO, ANDRÉ D'AVILA Tags: Original Clinical Source Type: research

Abstract 227: Prescribing Warfarin at Discharge for Heart Failure Patients without Atrial Fibrillation Findings from the Get With The Guidelines-Heart Failure Registry Poster Session II
Conclusions: Approximately 1 in 10 HF patients without AF or other documented indications are prescribed warfarin at discharge, and prescription rates vary widely across hospitals. Further research is needed to understand why anticoagulation is prescribed to patients with HF in the absence of documented indications.
Source: Circulation: Cardiovascular Quality and Outcomes - May 15, 2013 Category: Cardiology Authors: Eapen, Z., Grau-Sepulveda, M., Fonarow, G., Heidenreich, P., Peterson, E., Hernandez, A. Tags: Poster Session II Source Type: research

Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system
Abstract: Background: TAVI is a novel treatment option for patients at too high risk for surgery. Risk scores for surgical valve replacement failed to accurately predict outcomes after TAVI and alternative risk parameters are lacking so far.Objective: We evaluated the CT-derived aortic valve calcification score as a predictor for outcome during and after TAVI.Methods: Transfemoral TAVI using the CoreValve device was performed in 68 patients, in whom the aortic valve calcium score was determined from preprocedural 64-sclice ECG gated CT-scans.Results: 30-day MACE rate (death, stroke, MI) was 10.3%, 1-year mortality was 11.8...
Source: International Journal of Cardiology - December 26, 2011 Category: Cardiology Authors: Alexander W. Leber, Markus Kasel, Thomas Ischinger, Ulrich H. Ebersberger, Diethmar Antoni, Martin Schmidt, Gotthard Riess, Vivian Renz, Armin Huber, Thomas Helmberger, Ellen Hoffmann Tags: Original Articles Source Type: research

Transcatheter aortic valve implantation improves outcome compared to open-heart surgery in kidney transplant recipients requiring aortic valve replacement.
CONCLUSIONS: Based on our center's experience, TAVI appears to be an effective and safe alternative to conventional surgery for AVR in patients with prior renal transplantation. Renal transplantation is not currently identified as a risk factor in our traditional scoring system, and may need to be considered independently when weighing alternatives for AVR. PMID: 23611171 [PubMed - as supplied by publisher]
Source: Journal of Cardiology - April 20, 2013 Category: Cardiology Authors: Fox H, Büttner S, Hemmann K, Asbe-Vollkopf A, Doss M, Beiras-Fernandez A, Moritz A, Zeiher AM, Scheuermann E, Geiger H, Fichtlscherer S, Hauser IA, Lehmann R Tags: J Cardiol Source Type: research

The Transaortic Approach for Transcatheter Aortic Valve Replacement Initial Clinical Experience in the United States
ConclusionsTAVR via the TAO approach is technically feasible, seems to be associated with favorable outcomes, and expands the current alternative options for access sites in patients with inoperable aortic stenosis who are ineligible for TF TAVR.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - June 3, 2013 Category: Cardiology Source Type: research

The Transaortic Approach for Transcatheter Aortic Valve Replacement: Initial Clinical Experience in the United States
Conclusions: TAVR via the TAO approach is technically feasible, seems to be associated with favorable outcomes, and expands the current alternative options for access sites in patients with inoperable aortic stenosis who are ineligible for TF TAVR.
Source: Journal of the American College of Cardiology - April 12, 2013 Category: Cardiology Authors: Joel A. Lardizabal, Brian P. O'Neill, Harit V. Desai, Conrad J. Macon, Alexis P. Rodriguez, Claudia A. Martinez, Carlos E. Alfonso, Martin S. Bilsker, Roger G. Carillo, Mauricio G. Cohen, Alan W. Heldman, William W. O'Neill, Donald B. Williams Tags: Interventional Cardiology Source Type: research

Percutaneous Endocardial Occlusion of Incompletely Surgically Ligated Left Atrial Appendage
ConclusionPercutaneous endocardial occlusion of ISLL is feasible using an Amplatzer Septal Occluder device. Additional studies are required to evaluate the long‐term safety and efficacy of this therapeutic treatment strategy in patients with ISLL.
Source: Journal of Cardiovascular Electrophysiology - June 10, 2013 Category: Cardiology Authors: ARASH ARYANA, DIOGO CAVACO, ARVIN ARTHUR, PADRAIG GEAROID O'NEILL, PEDRO ADRAGÃO, ANDRÉ D'AVILA Tags: Original Article Source Type: research

Comparison of Characteristics and Short-Term Outcome From Fungal Infective Endocarditis in Prosthetic Valve Endocarditis Versus Native Valve Endocarditis
In conclusion, fungal IE is associated with high mortality and recurrence rates. Surgery performed in selected cases may improve the outcomes, but the recurrence rate remains high.
Source: The American Journal of Cardiology - April 5, 2013 Category: Cardiology Authors: Xiao-lu Sun, Jian Zhang, Guo-gan Wang, Xiao-feng Zhuang, Yan-min Yang, Jun Zhu, Hui-qiong Tan, Li-tian Yu Tags: Valvular Heart Disease Source Type: research

Impact of Aortic Valve Replacement on Outcome of Symptomatic Patients with Severe Aortic Stenosis with Low Gradient and Preserved Left Ventricular Ejection Fraction.
CONCLUSIONS: AVR is associated with better survival than medical therapy in patients with symptomatic low gradient severe AS and preserved LVEF. PMID: 23812184 [PubMed - as supplied by publisher]
Source: Circulation - June 27, 2013 Category: Cardiology Authors: Ozkan A, Hachamovitch R, Kapadia SR, Tuzcu EM, Marwick TH Tags: Circulation Source Type: research